nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—kidney cancer—nephrolithiasis	0.946	1	CtDrD
Temsirolimus—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.00154	0.0384	CcSEcCtD
Temsirolimus—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.00142	0.0353	CcSEcCtD
Temsirolimus—CYP3A4—urine—nephrolithiasis	0.00134	0.0965	CbGeAlD
Temsirolimus—CYP2D6—urine—nephrolithiasis	0.00132	0.095	CbGeAlD
Temsirolimus—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00126	0.0313	CcSEcCtD
Temsirolimus—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00118	0.0293	CcSEcCtD
Temsirolimus—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00116	0.0836	CbGeAlD
Temsirolimus—MTOR—renal system—nephrolithiasis	0.00111	0.0803	CbGeAlD
Temsirolimus—MTOR—kidney—nephrolithiasis	0.00108	0.0777	CbGeAlD
Temsirolimus—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00101	0.025	CcSEcCtD
Temsirolimus—FKBP1A—renal system—nephrolithiasis	0.001	0.0722	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.000991	0.0716	CbGeAlD
Temsirolimus—FKBP1A—kidney—nephrolithiasis	0.000967	0.0698	CbGeAlD
Temsirolimus—FKBP1A—cortex of kidney—nephrolithiasis	0.000942	0.068	CbGeAlD
Temsirolimus—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.000928	0.0231	CcSEcCtD
Temsirolimus—Swelling—Hydrochlorothiazide—nephrolithiasis	0.000915	0.0228	CcSEcCtD
Temsirolimus—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.000856	0.0213	CcSEcCtD
Temsirolimus—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.000808	0.0201	CcSEcCtD
Temsirolimus—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00078	0.0194	CcSEcCtD
Temsirolimus—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.000757	0.0188	CcSEcCtD
Temsirolimus—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00074	0.0184	CcSEcCtD
Temsirolimus—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.000735	0.0183	CcSEcCtD
Temsirolimus—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000727	0.0181	CcSEcCtD
Temsirolimus—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.000715	0.0178	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000712	0.0177	CcSEcCtD
Temsirolimus—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.000703	0.0175	CcSEcCtD
Temsirolimus—Influenza—Hydrochlorothiazide—nephrolithiasis	0.000698	0.0174	CcSEcCtD
Temsirolimus—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.000698	0.0174	CcSEcCtD
Temsirolimus—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.000653	0.0162	CcSEcCtD
Temsirolimus—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000653	0.0162	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.000649	0.0161	CcSEcCtD
Temsirolimus—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.000645	0.016	CcSEcCtD
Temsirolimus—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00063	0.0157	CcSEcCtD
Temsirolimus—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.000626	0.0156	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.000617	0.0153	CcSEcCtD
Temsirolimus—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.000612	0.0152	CcSEcCtD
Temsirolimus—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000605	0.015	CcSEcCtD
Temsirolimus—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.000605	0.015	CcSEcCtD
Temsirolimus—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000593	0.0148	CcSEcCtD
Temsirolimus—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.000587	0.0146	CcSEcCtD
Temsirolimus—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.000584	0.0145	CcSEcCtD
Temsirolimus—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00056	0.0139	CcSEcCtD
Temsirolimus—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000555	0.0138	CcSEcCtD
Temsirolimus—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00055	0.0137	CcSEcCtD
Temsirolimus—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.000528	0.0131	CcSEcCtD
Temsirolimus—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000486	0.0121	CcSEcCtD
Temsirolimus—CYP3A5—nephron tubule—nephrolithiasis	0.000479	0.0346	CbGeAlD
Temsirolimus—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000476	0.0118	CcSEcCtD
Temsirolimus—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00047	0.0117	CcSEcCtD
Temsirolimus—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00045	0.0112	CcSEcCtD
Temsirolimus—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000444	0.0111	CcSEcCtD
Temsirolimus—CYP3A5—renal system—nephrolithiasis	0.000436	0.0315	CbGeAlD
Temsirolimus—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000435	0.0108	CcSEcCtD
Temsirolimus—Cough—Hydrochlorothiazide—nephrolithiasis	0.000424	0.0106	CcSEcCtD
Temsirolimus—CYP3A5—kidney—nephrolithiasis	0.000421	0.0304	CbGeAlD
Temsirolimus—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000414	0.0103	CcSEcCtD
Temsirolimus—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000414	0.0103	CcSEcCtD
Temsirolimus—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000414	0.0103	CcSEcCtD
Temsirolimus—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000413	0.0103	CcSEcCtD
Temsirolimus—CYP3A5—cortex of kidney—nephrolithiasis	0.00041	0.0296	CbGeAlD
Temsirolimus—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000397	0.00987	CcSEcCtD
Temsirolimus—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000397	0.00987	CcSEcCtD
Temsirolimus—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000389	0.00967	CcSEcCtD
Temsirolimus—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000378	0.00941	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000362	0.009	CcSEcCtD
Temsirolimus—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000359	0.00893	CcSEcCtD
Temsirolimus—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000354	0.0088	CcSEcCtD
Temsirolimus—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000353	0.00878	CcSEcCtD
Temsirolimus—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000345	0.00858	CcSEcCtD
Temsirolimus—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000342	0.00851	CcSEcCtD
Temsirolimus—Pain—Hydrochlorothiazide—nephrolithiasis	0.000339	0.00844	CcSEcCtD
Temsirolimus—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000339	0.00844	CcSEcCtD
Temsirolimus—CYP3A4—renal system—nephrolithiasis	0.000327	0.0236	CbGeAlD
Temsirolimus—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000325	0.00807	CcSEcCtD
Temsirolimus—CYP2D6—renal system—nephrolithiasis	0.000322	0.0232	CbGeAlD
Temsirolimus—CYP3A4—kidney—nephrolithiasis	0.000316	0.0228	CbGeAlD
Temsirolimus—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000314	0.00781	CcSEcCtD
Temsirolimus—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000314	0.00781	CcSEcCtD
Temsirolimus—CYP2D6—kidney—nephrolithiasis	0.000311	0.0225	CbGeAlD
Temsirolimus—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000292	0.00727	CcSEcCtD
Temsirolimus—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000285	0.00708	CcSEcCtD
Temsirolimus—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000281	0.00699	CcSEcCtD
Temsirolimus—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000272	0.00676	CcSEcCtD
Temsirolimus—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000262	0.00653	CcSEcCtD
Temsirolimus—ABCB1—nephron tubule—nephrolithiasis	0.000255	0.0184	CbGeAlD
Temsirolimus—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000252	0.00628	CcSEcCtD
Temsirolimus—Rash—Hydrochlorothiazide—nephrolithiasis	0.00025	0.00623	CcSEcCtD
Temsirolimus—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00025	0.00622	CcSEcCtD
Temsirolimus—Headache—Hydrochlorothiazide—nephrolithiasis	0.000249	0.00619	CcSEcCtD
Temsirolimus—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000236	0.00587	CcSEcCtD
Temsirolimus—ABCB1—renal system—nephrolithiasis	0.000231	0.0167	CbGeAlD
Temsirolimus—ABCB1—kidney—nephrolithiasis	0.000224	0.0162	CbGeAlD
Temsirolimus—ABCB1—cortex of kidney—nephrolithiasis	0.000218	0.0157	CbGeAlD
